Calming the cytokine storm in COVID-19
RQ Cron, R Caricchio, WW Chatham - Nature medicine, 2021 - nature.com
Calming the cytokine storm in COVID-19 | Nature Medicine Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …
Preventing mortality in COVID-19 patients: which cytokine to target in a raging storm?
L Lu, H Zhang, M Zhan, J Jiang, H Yin… - Frontiers in cell and …, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19) from severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection has resulted in tremendous morbidity and mortality worldwide. A …
2 (SARS-CoV-2) infection has resulted in tremendous morbidity and mortality worldwide. A …
An inflammatory cytokine signature predicts COVID-19 severity and survival
DM Del Valle, S Kim-Schulze, HH Huang… - Nature medicine, 2020 - nature.com
Several studies have revealed that the hyper-inflammatory response induced by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease …
[HTML][HTML] Cytokine storm intervention in the early stages of COVID-19 pneumonia
X Sun, T Wang, D Cai, Z Hu, H Liao, L Zhi, H Wei… - Cytokine & growth factor …, 2020 - Elsevier
Clinical intervention in patients with corona virus disease 2019 (COVID-19) has
demonstrated a strong upregulation of cytokine production in patients who are critically ill …
demonstrated a strong upregulation of cytokine production in patients who are critically ill …
[PDF][PDF] Cytokine-targeted therapy in severely ill COVID-19 patients: options and cautions
M Rahmati, MA Moosavi - mortality, 2020 - researchgate.net
Dear Editor, Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) with the symptoms …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) with the symptoms …
Blocking IL-1 to prevent respiratory failure in COVID-19
FL Van de Veerdonk, MG Netea - Critical Care, 2020 - Springer
COVID-19 is an emerging disease that can manifest itself as asymptomatic or mild
respiratory tract infection in the majority of individuals, but in some, it can progress into …
respiratory tract infection in the majority of individuals, but in some, it can progress into …
Immunomodulation in COVID-19
NE Ingraham, S Lotfi-Emran, BK Thielen… - The Lancet …, 2020 - thelancet.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome corona virus 2 (SARS-CoV-2), continues to spread globally despite …
syndrome corona virus 2 (SARS-CoV-2), continues to spread globally despite …
Fighting COVID-19 exhausts T cells
C Moon - Nature Reviews Immunology, 2020 - nature.com
Acute respiratory distress syndrome (ARDS) and robust cytokine storm are the hallmark of
severe COVID-19 cases. Using single-cell RNA sequencing of bronchoalveolar lavage fluid …
severe COVID-19 cases. Using single-cell RNA sequencing of bronchoalveolar lavage fluid …
Respiratory impairment predicts response to IL-1 and IL-6 blockade in COVID-19 patients with severe pneumonia and hyper-inflammation
Background Restraining maladaptive inflammation is considered a rationale strategy to treat
severe coronavirus disease-19 (COVID-19) but available studies with selective inhibitors of …
severe coronavirus disease-19 (COVID-19) but available studies with selective inhibitors of …
Cytokine release syndrome in severe COVID-19
In December 2019, a new strain of coronavirus, severe acute respiratory syndrome–
coronavirus 2 (SARS-CoV-2), was recognized to have emerged in Wuhan, China. Along …
coronavirus 2 (SARS-CoV-2), was recognized to have emerged in Wuhan, China. Along …